Townsend, K L
Tseng, Y-H
Article History
Received: 31 December 2013
Accepted: 12 February 2015
First Online: 4 August 2015
Competing interests
: Y-HT has received consulting fees from Ember Therapeutics, lecture fees from Pfizer Inc., and received grant support from Chugai Pharma Co., Ltd and MedImmune LLC. KLT declares no conflict of interest.